Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
45,708,039
-
Share change
-
+10,093,605
-
Total reported value
-
$170,463,101
-
Put/Call ratio
-
116%
-
Price per share
-
$3.73
-
Number of holders
-
118
-
Value change
-
+$37,582,880
-
Number of buys
-
60
-
Number of sells
-
35
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q1 2019
As of 31 Mar 2019,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,708,039 shares.
The largest 10 holders included
BlackRock Inc., WASATCH ADVISORS INC, VANGUARD GROUP INC, STATE STREET CORP, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., ARK Investment Management LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP.
This page lists
118
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.